This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes.
The latest data on safety and efficacy of do...lutegravir (DTG) containing regimens were also reviewed. The document identified the remaining gaps in knowledge, research, monitoring, and surveillance on DTG and TLD transition and listed the future priorities.
more
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat...ing and emerging variants.
more
The latest on the COVID-19 global situation & long term sequelae, March 2021
UNAIDS/WHO 2015 | Reference
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...B (RR/MDR-TB), only 206 030 (44%) were diagnosed and notified.For the first time, the World Health Organization (WHO) has provided global estimates of the incidence of isoniazid resistance: in 2019, there were 1.4 million incident cases of isoniazid-resistant TB, of which 1.1 million were susceptible to rifampicin. Most of these people were not diagnosed with drug-resistant TB and did not receive appropriate treatment.
more
Also available in a Myanmar language version
Presentation on chikungunya a and chikungunya vaccines
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...lowlights’—that have occurred over the last year.
more
An update of Yellow Fever outbreak in Nigeria, regularly updates
I SURVIVED EBOLA:THANKS TO ASEOWA
Alimatou Camara Speaks of her battle with Ebola and of the Care she received at the ASEOWA run Ebola Treatment Unit in Guinea
Guinean Alimatou Camara, a seventeen year old housewife in a polygamous union, lost her mother in-law, her only daughter and her stepdau...ghter to Ebola. She got infected too, but survived, thanks to the African Union Support to Ebola Outbreak in West Africa (ASEOWA).
By Lilas Belepe,
Communication Officer, ASEOWA Guinee
A resident of Forécariah, a town situated one hundred kilometres away from Conakry, the capital of Guinea, she narrates the ordeal that befell her and her family, her battle with Ebola and the time she spent recovering at the African Union run Ebola Treatment Unit (ETU), in Coyah.
more
760 WEEKLY EPIDEMIOLOGICAL RECORD, NOS. 51/52, 20 DECEMBER 2024, pp.760-769. In French and English
as of 12:00 AM, 17 September 2018 - 6:00 AM, 17 September 2018